VBI Vaccines Inc. (VBIV) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for VBI Vaccines Inc., with annual and quarterly history.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.10x | -0.71x | -8.21x | -12.69x | -2.95x | -1.65x |
| P/B Ratio | 1.22x | 1.57x | 4.15x | 3.50x | 1.87x | 1.07x |
| P/S Ratio | 1.05x | 93.09x | 945.45x | 565.73x | 74.22x | 31.31x |
| Profitability | ||||||
| Gross Margin | -67.0% | -942.1% | -1606.8% | -764.1% | -255.9% | -34.4% |
| Operating Margin | -637.1% | -7561.9% | -10781.6% | -4110.9% | -2359.3% | -1800.5% |
| Net Margin | -1069.3% | -13026.9% | -11513.5% | -4456.7% | -2512.6% | -1895.7% |
| EBITDA Margin | -953.5% | -9798.5% | -9954.7% | -3888.5% | -2314.9% | -1776.1% |
| Liquidity | ||||||
| Current Ratio | 0.48x | 2.10x | 4.00x | 7.61x | 1.58x | 2.64x |
| Quick Ratio | 0.37x | 2.10x | 3.92x | 7.49x | 1.54x | 2.60x |
| Leverage | ||||||
| Debt/Equity | 7.05x | 0.81x | 0.22x | 0.01x | 0.17x | 0.14x |
YoY = year-over-year change. Source: FMP..